Barclays analyst Lauren Lieberman lowered the firm’s price target on Brown-Forman (BF.B) to $31 from $38 and keeps an Overweight rating on the shares. The company’s fiscal 2026 guidance for a low-single-digit decline on organic sales and operating profit came in well below market expectations, the analyst tells investors in a research note. The firm says the outlook will add fuel to the “already lively” structural versus cyclical debate around beverage alcohol. However, Barclays believes there was little from Brown-Forman’s update to suggest the weakness is a result of a permanent change in consumer demand.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BF.B:
- Brown-Forman downgraded to Neutral from Outperform at BNP Paribas Exane
- Brown-Forman Reports Fiscal 2025 Earnings Amid Challenges
- Brown-Forman Stock (BF.B) Crashes 18% after Alcohol Giant Warns of Tariff Risks
- Trump-Xi call focuses on trade, PVH reports Q2 beat: Morning Buzz
- Morning Movers: Brown-Forman plummets following fourth quarter results